Harpreet Singh1, Julia A Beaver2, Geoffrey Kim2, Richard Pazdur2. 1. Office of Hematology and Oncology Products, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD, United States. Electronic address: Harpreet.Singh@fda.hhs.gov. 2. Office of Hematology and Oncology Products, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD, United States.
Authors: Shirley M Bluethmann; Christopher N Sciamanna; Renate M Winkels; Kathleen M Sturgeon; Kathryn H Schmitz Journal: Am J Lifestyle Med Date: 2018-02-07
Authors: Melisa L Wong; Stuart M Lichtman; Gary R Morrow; John Simmons; Tomma Hargraves; Cary P Gross; Jennifer L Lund; Lisa M Lowenstein; Louise C Walter; Cara L McDermott; Supriya G Mohile; Harvey Jay Cohen Journal: J Geriatr Oncol Date: 2019-07-17 Impact factor: 3.599
Authors: Isabela M Bumanlag; Joseph Abi Jaoude; Michael K Rooney; Cullen M Taniguchi; Ethan B Ludmir Journal: Semin Radiat Oncol Date: 2022-04 Impact factor: 5.934
Authors: Mina S Sedrak; Rachel A Freedman; Harvey J Cohen; Hyman B Muss; Aminah Jatoi; Heidi D Klepin; Tanya M Wildes; Jennifer G Le-Rademacher; Gretchen G Kimmick; William P Tew; Kevin George; Simran Padam; Jennifer Liu; Andrew R Wong; Andrea Lynch; Benjamin Djulbegovic; Supriya G Mohile; William Dale Journal: CA Cancer J Clin Date: 2020-10-01 Impact factor: 508.702